Nourish Raises $100M to Expand GLP-1 Weight Loss Support Program
Nourish just raised 100 million dollars in its latest funding round. Menlo Ventures led the investment. Now, the company…
-
-
Eli Lilly’s Orforglipron Positions to Challenge Novo Nordisk’s Oral GLP-1 Lead
Eli Lilly is preparing to launch a new weight-loss pill called orforglipron. They expect the government to approve it…
-
The Battle for the Daily Weight Loss Pill: Novo Nordisk Faces Off Against Eli Lilly
Eli Lilly is eating into the injectable weight management market at a blistering pace. That leaves Novo Nordisk scrambling…
